Ketamine Withdrawn Phase 3 Trials for Epilepsies / refractory seizure disorders Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02726867Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus